Compared with HER2-negative breast cancer, semiquantitative kinetic parameter maps of HER2-positive breast cancer showed higher contrast, autocorrelation, and gray level nonuniformity, as well as lower short run emphasis in the training set. The gene discussed is ERBB2; the disease is breast cancer.